HHS Reg Reform Committee To Discuss Adverse Event Reporting June 10
HHS' advisory committee on regulatory reform will discuss adverse event reporting during its June 10-11 meeting in Minneapolis, Minn
You may also be interested in...
The HHS Advisory Committee on Regulatory Reform will hear a presentation from the Center for Drug Evaluation & Research as an example of "best practices" during its inaugural meeting
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials